Summary
Differentials
Common
- Alcohol induced
- Hepatic steatosis
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis
- Haemochromatosis
- Hodgkin's lymphoma
- Non-Hodgkin's lymphoma (NHL)
- Waldenström's macroglobulinaemia or lymphoplasmacytic lymphoma
- Acute myeloid leukaemia (AML)
- Chronic myeloid leukaemia (CML)
- Acute lymphoblastic leukaemia (ALL)
- Chronic lymphocytic leukaemia (CLL)
- Hairy cell leukaemia
- Myelofibrosis
- Polycythaemia vera
- Essential thrombocytosis
- Splenic metastases
- Autoimmune haemolytic anaemia
- Rheumatoid arthritis (RA)
- Felty syndrome
- Systemic lupus erythematosus
- Sarcoidosis
- Malaria
- Epstein-Barr virus (EBV)
- Endocarditis
- Sepsis-related splenic abscesses
- Chronic hepatitis C
- Chronic hepatitis B
- Sickle cell anaemia
- Cytoskeletal defects
- Thalassaemias
Uncommon
- Benign splenic tumours
- Portal vein thrombosis
- Splenic vein thrombosis
- Budd-Chiari syndrome
- Haemophagocytic lymphohistiocytosis (HLH)
- Amyloidosis
- Gaucher's or Niemann-Pick disease
- Severe dengue
- Splenic rupture
- Subcapsular haemorrhage
- Secondary to granulocyte colony-stimulating factor (G-CSF)
Contributors
Authors
Terri L. Parker, MD
Assistant Professor of Medicine
Section of Hematology
Yale School of Medicine
Smilow Cancer Center at Yale-New Haven
New Haven
CT
Disclosures
TLP declares that she has no competing interests.
Acknowledgements
Dr Terri L. Parker would like to gratefully acknowledge Dr Alan E. Lichtin, the previous contributor to this monograph.
Disclosures
AEL has received research support from Amgen.
Peer reviewers
Priyanka Mehta, MD
Consultant Haematologist
Bristol Haematology and Oncology Centre
Bristol
UK
Disclosures
PM declares that she has no competing interests.
Ruben A. Mesa, MD
Professor of Medicine
Mayo Clinic
Scottsdale
AZ
Disclosures
RAM declares that he has no competing interests.
Giovanni Barosi, MD
Director of the Laboratory of Clinical Epidemiology
IRCCS Policlinico S. Matteo Foundation
Pavia
Italy
Disclosures
GB declares that he has no competing interests.
Guidelines
- Points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
- WHO Guidelines for malaria
More GuidelinesPatient information
Hepatitis B: should I have the vaccine?
Hepatitis C: what is it?
More Patient information- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer